O. Oberlin

723 total citations
26 papers, 487 citations indexed

About

O. Oberlin is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, O. Oberlin has authored 26 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Pathology and Forensic Medicine and 7 papers in Surgery. Recurrent topics in O. Oberlin's work include Sarcoma Diagnosis and Treatment (14 papers), Hematological disorders and diagnostics (5 papers) and Tumors and Oncological Cases (4 papers). O. Oberlin is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Hematological disorders and diagnostics (5 papers) and Tumors and Oncological Cases (4 papers). O. Oberlin collaborates with scholars based in France, United States and Italy. O. Oberlin's co-authors include Annie Rey, Michela Casanova, Giovanni Cecchetto, Daniel Orbach, Marcelo Scopinaro, Gianni Bisogno, Estelle Thébaud, Andrea Ferrari, Modesto Carli and Anna T. Meadows and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and British Journal Of Nutrition.

In The Last Decade

O. Oberlin

25 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Oberlin France 12 251 174 144 102 90 26 487
Strong Lc United States 3 317 1.3× 83 0.5× 102 0.7× 73 0.7× 200 2.2× 4 606
M.C. Demaille France 11 240 1.0× 101 0.6× 86 0.6× 124 1.2× 98 1.1× 20 495
Pratt Cb United States 12 208 0.8× 130 0.7× 45 0.3× 56 0.5× 157 1.7× 20 509
J. Otten Belgium 11 344 1.4× 181 1.0× 112 0.8× 63 0.6× 130 1.4× 18 490
Daniela Katz Israel 12 365 1.5× 74 0.4× 71 0.5× 103 1.0× 323 3.6× 29 620
H. J�rgens Germany 9 157 0.6× 122 0.7× 32 0.2× 46 0.5× 46 0.5× 12 345
Voûte Pa Netherlands 13 294 1.2× 91 0.5× 69 0.5× 117 1.1× 78 0.9× 39 498
Amr El Weshi Saudi Arabia 12 154 0.6× 329 1.9× 39 0.3× 143 1.4× 121 1.3× 17 515
Robert G. Gagliano United States 11 216 0.9× 65 0.4× 143 1.0× 43 0.4× 150 1.7× 16 673
Philippe Tron France 10 170 0.7× 68 0.4× 74 0.5× 67 0.7× 63 0.7× 10 391

Countries citing papers authored by O. Oberlin

Since Specialization
Citations

This map shows the geographic impact of O. Oberlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Oberlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Oberlin more than expected).

Fields of papers citing papers by O. Oberlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Oberlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Oberlin. The network helps show where O. Oberlin may publish in the future.

Co-authorship network of co-authors of O. Oberlin

This figure shows the co-authorship network connecting the top 25 collaborators of O. Oberlin. A scholar is included among the top collaborators of O. Oberlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Oberlin. O. Oberlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Habrand, Jean Louis, et al.. (2014). Esthesioneuroblastoma in Children and Adolescent. Journal of Pediatric Hematology/Oncology. 36(2). 91–95. 25 indexed citations
2.
Bautista, Francisco, Angela Di Giannatale, Mony Fahd, et al.. (2014). Patients in Pediatric Phase I and Early Phase II Clinical Oncology Trials at Gustave Roussy. Journal of Pediatric Hematology/Oncology. 37(2). e102–e110. 23 indexed citations
3.
Oberlin, O., Mhamed Harif, Giorgio Perilongo, et al.. (2014). In Memoriam—Jean Lemerle (1930–2014). Pediatric Blood & Cancer. 61(12). 2333–2334. 2 indexed citations
4.
Demoor‐Goldschmidt, Charlotte, et al.. (2011). Ameloblastic Fibrosarcoma of the Mandible. Journal of Pediatric Hematology/Oncology. 34(2). e72–e76. 17 indexed citations
5.
Oberlin, O., M. Le Deley, Uta Dirksen, et al.. (2011). Randomized comparison of VAC versus VAI chemotherapy (CT) as consolidation for standard risk (SR) Ewing sarcoma tumor (ES): Results of the Euro-EWING.99-R1 trial.. Journal of Clinical Oncology. 29(15_suppl). 9517–9517. 10 indexed citations
6.
Merks, Johannes H. M., Gian Luca De Salvo, Gianni Bisogno, et al.. (2011). Parameningeal rhabdomyosarcoma: Results of a pooled analysis from U.S. and European Cooperative Groups.. Journal of Clinical Oncology. 29(15_suppl). 9529–9529. 3 indexed citations
7.
Whelan, J. T., et al.. (2007). Multivariate analysis based risk grouping of ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study. Journal of Clinical Oncology. 25(18_suppl). 9562–9562. 1 indexed citations
8.
Oberlin, O., et al.. (2006). Goitre and iodine deficiency in Afghanistan: a case—control study. British Journal Of Nutrition. 95(1). 196–203. 12 indexed citations
9.
Bouligand, Jérôme, Thomas Storme, O. Oberlin, et al.. (2005). Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products. Journal of Pharmaceutical and Biomedical Analysis. 38(1). 180–185. 12 indexed citations
10.
Janot, François, O. Oberlin, G Schwaab, et al.. (2002). [Pediatric rhabdomyosarcoma of the infratemporal fossa].. PubMed. 119(4). 195–201. 1 indexed citations
11.
Rechnitzer, Catherine, Marcelo Scopinaro, Felix Niggli, et al.. (2001). Treatment of non metastatic peripheral primitive neuroectodermal tumour (PNET)/Extra osseous Ewing's sarcoma (EOES): experience in the SIOP MMT 89 study. European Journal of Cancer. 37. S336–S336. 1 indexed citations
12.
Oberlin, O., et al.. (2000). 114 The place of brachytherapy (bt) in the conservative approach of pediatric vesicoprostatic rhabdomyosarcomas (RMS) treatment. Radiotherapy and Oncology. 55. 62–62. 1 indexed citations
13.
Haie‐Méder, Christine, O. Oberlin, Hélène Martelli, et al.. (2000). [Brachytherapy in the treatment of vesicoprostatic rhabdomyosarcomas in children].. PubMed. 4 Suppl 1. 145s–149s. 11 indexed citations
14.
Coutant, R., F Pein, C. Adamsbaum, et al.. (1999). Prognosis of Children with Malignant Pheochromocytoma. Hormone Research in Paediatrics. 52(3). 145–149. 11 indexed citations
15.
Habrand, J.L., D. Spooner, A. Rey, et al.. (1997). 15 The role or radiation therapy (RT) in the management of localized soft tissue sarcomas (STS) in children a report of the international society of pediatric oncology (SIOP). International Journal of Radiation Oncology*Biology*Physics. 39(2). 142–142. 2 indexed citations
16.
Hartmann, Olivier, O. Oberlin, F Beaujean, et al.. (1990). [Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children].. Bulletin du Cancer. 77(2). 181–7. 21 indexed citations
17.
Meadows, Anna T., Osvaldo Marrero, O. Oberlin, et al.. (1989). Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Medical and Pediatric Oncology. 17(5-6). 477–484. 138 indexed citations
18.
Lemerle, Jean & O. Oberlin. (1989). Current management and controversies. Cancer treatment and research. 41. 129–143. 3 indexed citations
19.
Leverger, G, O. Oberlin, G Schaison, & J Lemerle. (1987). [Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].. PubMed. 29(1). 83–5. 1 indexed citations
20.
Deméocq, F, et al.. (1984). [Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol].. PubMed. 13(12). 717–21. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Strong Lc Breakdown of academic impact, for papers by M.C. Demaille Breakdown of academic impact, for papers by Pratt Cb Breakdown of academic impact, for papers by J. Otten Breakdown of academic impact, for papers by Daniela Katz Breakdown of academic impact, for papers by H. J�rgens Breakdown of academic impact, for papers by Voûte Pa Breakdown of academic impact, for papers by Amr El Weshi Breakdown of academic impact, for papers by Robert G. Gagliano Breakdown of academic impact, for papers by Philippe Tron
Rankless by CCL
2026